Published in Chem Commun (Camb) on October 07, 2003
Highly practical copper(I)/TEMPO catalyst system for chemoselective aerobic oxidation of primary alcohols. J Am Chem Soc (2011) 1.64
Aerobic copper-catalyzed organic reactions. Chem Rev (2013) 1.54
Practical aerobic oxidations of alcohols and amines with homogeneous copper/TEMPO and related catalyst systems. Angew Chem Int Ed Engl (2014) 1.09
Mechanism of copper(I)/TEMPO-catalyzed aerobic alcohol oxidation. J Am Chem Soc (2013) 0.97
Mechanism of alcohol oxidation mediated by copper(II) and nitroxyl radicals. J Am Chem Soc (2014) 0.92
Development and comparison of the substrate scope of Pd-catalysts for the aerobic oxidation of alcohols. J Org Chem (2005) 0.89
Cu/Nitroxyl Catalyzed Aerobic Oxidation of Primary Amines into Nitriles at Room Temperature. ACS Catal (2013) 0.84
Highly efficient Cu(I)-catalyzed oxidation of alcohols to ketones and aldehydes with diaziridinone. Org Lett (2013) 0.82
Second-Order Biomimicry: In Situ Oxidative Self-Processing Converts Copper(I)/Diamine Precursor into a Highly Active Aerobic Oxidation Catalyst. ACS Cent Sci (2017) 0.75
Improving catalytic function by ProSAR-driven enzyme evolution. Nat Biotechnol (2007) 2.36
Valorization of biomass: deriving more value from waste. Science (2012) 1.73
Green, catalytic oxidations of alcohols. Acc Chem Res (2002) 1.63
Biocatalysis in ionic liquids. Chem Rev (2007) 1.56
Self-assembly of a heteropolyoxopalladate nanocube: [Pd(II)13As(V)8O34(OH)6]8-. Angew Chem Int Ed Engl (2008) 1.54
Putting anion-π interactions into perspective. Angew Chem Int Ed Engl (2011) 1.49
Anion binding involving pi-acidic heteroaromatic rings. Acc Chem Res (2007) 1.33
Biocatalytic transformations in ionic liquids. Trends Biotechnol (2003) 1.27
Immobilised enzymes: carrier-bound or carrier-free? Curr Opin Biotechnol (2003) 1.21
[Fe(mu-btzmp)2(btzmp)2](ClO4)2: a doubly-bridged 1D spin-transition bistetrazole-based polymer showing thermal hysteresis behaviour. Dalton Trans (2007) 1.10
catena-Poly[[dicyanamido(5,5'-dimethyl-2,2'-bipyridine-kappa2N,N')copper(II)]-mu-dicyanamido-kappa2N1:N5]. Acta Crystallogr C (2002) 1.10
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole. J Am Chem Soc (2002) 1.09
Are natural deep eutectic solvents the missing link in understanding cellular metabolism and physiology? Plant Physiol (2011) 1.08
Unique ligand-based oxidative DNA cleavage by zinc(II) complexes of hpyramol and hpyrimol. Chemistry (2007) 1.07
Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L= o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]. J Biol Inorg Chem (2004) 1.05
Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. ChemMedChem (2008) 1.01
Strongly isolated ferromagnetic layers in poly-trans-mu-dichloro- and poly-trans-mu-dibromobis(1-(2-chloroethyl)-tetrazole-N4)copper(II) complexes. Inorg Chem (2002) 1.01
Mimicking nature: synthetic nicotinamide cofactors for C═C bioreduction using enoate reductases. Org Lett (2012) 0.98
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J Inorg Biochem (2002) 0.96
Cu(II)-nitroxyl radicals as catalytic galactose oxidase mimics. Org Biomol Chem (2003) 0.96
An aromatic anion receptor: anion-pi interactions do exist. Angew Chem Int Ed Engl (2004) 0.96
Bis[bis(2-pyridylcarbonyl)aminato]iron(III) perchlorate acetonitrile disolvate. Acta Crystallogr C (2006) 0.95
Synthetic models of the active site of catechol oxidase: mechanistic studies. Chem Soc Rev (2006) 0.94
Synthesis, characterization, in vitro antitumor activity, DNA-binding properties and electronic structure (DFT) of the new complex cis-(Cl,Cl)[RuIICl2(NO+)(terpy)]Cl. Dalton Trans (2005) 0.94
A Mixed-Valence Tetranuclear Copper Cluster with Localized Valencies. Inorg Chem (1997) 0.93
Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs. J Med Chem (2005) 0.93
New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity. Dalton Trans (2005) 0.93
Ruthenium(III) chloride complex with a tridentate bis(arylimino)pyridine ligand: synthesis, spectra, X-ray structure, 9-ethylguanine binding pattern, and in vitro cytotoxicity. Inorg Chem (2008) 0.91
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer (2008) 0.91
High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis. Clin Cancer Res (2009) 0.90
Visible light-driven and chloroperoxidase-catalyzed oxygenation reactions. Chem Commun (Camb) (2009) 0.90
Trigonal propeller-shaped [Mn(III)3M(II)Na] complexes (M = Mn, Ca): structural and functional models for the dioxygen evolving centre of PSII. Dalton Trans (2011) 0.89
2-Chloro-pyrimidin-4-amine. Acta Crystallogr Sect E Struct Rep Online (2012) 0.89
Structure-toxicity relationships for different types of dinuclear platinum complexes. J Inorg Biochem (2006) 0.89
The square-planar cytotoxic [Cu(II)(pyrimol)Cl] complex acts as an efficient DNA cleaver without reductant. J Am Chem Soc (2006) 0.89
Enzyme engineering for enantioselectivity: from trial-and-error to rational design? Trends Biotechnol (2009) 0.89
A new, mild cross-linking methodology to prepare cross-linked enzyme aggregates. Biotechnol Bioeng (2004) 0.88
A two-step, one-pot enzymatic synthesis of cephalexin from D-phenylglycine nitrile. Biotechnol Bioeng (2002) 0.88
Kinetic study of azole-bridged dinuclear platinum(II) complexes reacting with a hairpin-stabilized double-stranded oligonucleotide. J Inorg Biochem (2003) 0.88
Citations and ethics. Angew Chem Int Ed Engl (2011) 0.87
Penicillin acylase-catalyzed ampicillin synthesis using a pH gradient: a new approach to optimization. Biotechnol Bioeng (2002) 0.86
Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem (2005) 0.86
The taming of oxygen: biocatalytic oxyfunctionalisations. Chem Commun (Camb) (2014) 0.85
New approach for the preparation of efficient DNA cleaving agents: ditopic copper-platinum complexes based on 3-Clip-Phen and cisplatin. J Med Chem (2007) 0.85
Enhancement of the substrate scope of transketolase. Chembiochem (2012) 0.84
Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds? J Biol Inorg Chem (2008) 0.84
3-D lanthanide metal-organic frameworks: structure, photoluminescence, and magnetism. Inorg Chem (2009) 0.84
Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations. J Phys Chem B (2006) 0.83
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. J Inorg Biochem (2004) 0.83
A biocatalytic hydrogenation of carboxylic acids. Chem Commun (Camb) (2012) 0.82
Mini-review: recent developments in hydroxynitrile lyases for industrial biotechnology. Recent Pat Biotechnol (2013) 0.82
Self-assembly of star-shaped heteropoly-15-palladate(II). Dalton Trans (2009) 0.81
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. J Biol Inorg Chem (2004) 0.81
(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity. J Inorg Biochem (2002) 0.81
Platinated copper(3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents. Chemistry (2008) 0.81
Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5'-GMP and DNA. J Inorg Biochem (2004) 0.81
Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand. Biochem Pharmacol (2009) 0.81
Cross-linked aggregates of (R)-oxynitrilase: a stable, recyclable biocatalyst for enantioselective hydrocyanation. Org Lett (2005) 0.81
Controlled copper-mediated chlorination of phenol rings under mild conditions. Inorg Chem (2007) 0.81
Proton NMR spectroscopy and magnetic properties of a solution-stable dicopper(II) complex bearing a single mu-hydroxo bridge. Inorg Chem (2005) 0.81
Biochemical characterization of the carotenoid 1,2-hydratases (CrtC) from Rubrivivax gelatinosus and Thiocapsa roseopersicina. Appl Microbiol Biotechnol (2011) 0.80
Crystallographic evidence of nitrate-pi interactions involving the electron-deficient 1,3,5-triazine ring. Inorg Chem (2006) 0.80
Azole-bridged diplatinum anticancer compounds. Modulating DNA flexibility to escape repair mechanism and avoid cross resistance. J Phys Chem B (2007) 0.80
DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation. Dalton Trans (2009) 0.80
A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding. Chemistry (2006) 0.80
New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes. J Med Chem (2003) 0.80
Catecholase activity of a copper(II) complex with a macrocyclic ligand: unraveling catalytic mechanisms. Chemistry (2006) 0.80
Platinum complexes of diaminocarboxylic acids and their ethyl ester derivatives: the effect of the chelate ring size on antitumor activity and interactions with GMP and DNA. J Inorg Biochem (2003) 0.80
Evaluation of the performance of immobilized penicillin G acylase using active-site titration. Biotechnol Bioeng (2002) 0.80
Structure, cytotoxicity, and DNA-cleavage properties of the complex [Cu(II)(pbt)Br2]. Inorg Chem (2008) 0.79
Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands. J Inorg Biochem (2009) 0.79
Selective copper(II)-mediated oxidative coupling of a nucleophilic reagent to the para-methyl group of 2,4,6-trimethylphenol. Dalton Trans (2005) 0.79
A Unique Mononuclear Nickel Disulfonato Complex Obtained by Oxidation of a Mononuclear Nickel Dithiolate Complex. Inorg Chem (1997) 0.79
Two-step spin-transition iron(III) compound with a wide [high spin-low spin] plateau. Inorg Chem (2009) 0.79
Unique reactivity of a tetradentate N(2)S(2) complex of nickel: intermediates in the production of sulfur oxygenates. Inorg Chem (2002) 0.79
A copper complex bearing a TEMPO moiety as catalyst for the aerobic oxidation of primary alcohols. Dalton Trans (2008) 0.79
Concurrent anion...pi interactions between a perchlorate ion and two pi-acidic aromatic rings, namely pentafluorophenol and 1,3,5-triazine. Chem Commun (Camb) (2008) 0.78
The beta-glucuronyl-based prodrug strategy allows for its application on beta-glucuronyl-platinum conjugates. Bioorg Med Chem Lett (2004) 0.78
DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects. J Biol Inorg Chem (2008) 0.78
Noncovalent anchoring of asymmetric hydrogenation catalysts on a new mesoporous aluminosilicate: application and solvent effects. Chemistry (2004) 0.78
Interaction between the DNA model base 9-ethylguanine and a group of ruthenium polypyridyl complexes: kinetics and conformational temperature dependence. Inorg Chem (2007) 0.78
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells. J Biol Inorg Chem (2004) 0.78
Accurate non-invasive image-based cytotoxicity assays for cultured cells. BMC Biotechnol (2010) 0.78
Efficient immobilisation of Rh-MonoPhos on the aluminosilicate AlTUD-1. Chem Commun (Camb) (2004) 0.78
Automated parallel solid-phase synthesis and anticancer screening of a library of peptide-tethered platinum(II) complexes. J Comb Chem (2003) 0.78
Active site titration as a tool for the evaluation of immobilization procedures of penicillin acylase. Biotechnol Bioeng (2002) 0.78
Dichlorobis(2-phenylazopyridine)ruthenium(II) complexes: characterisation, spectroscopic and structural properties of four isomers. Dalton Trans (2004) 0.78
Crude aminoacylase from aspergillus sp. is a mixture of hydrolases. Biotechnol Bioeng (2003) 0.78
A two-step spin crossover mononuclear iron(II) complex with a [HS-LS-LS] intermediate phase. Chem Commun (Camb) (2008) 0.78
Copper-1,10-phenanthroline complexes binding to DNA: structural predictions from molecular simulations. J Phys Chem B (2009) 0.78
Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity. J Inorg Biochem (2005) 0.78
Loss of Hoogsteen pairing ability upon N1 adenine platinum binding. Inorg Chem (2002) 0.78